HIV Citations List: February 2023

Literature Citations

1. Bioassay Analysis and Molecular Docking Study Revealed the Potential Medicinal Activities of Active Compounds Polygonumins B, C and D from Polygonum minus (Persicaria minor). Ahmad, R., A.R. Rosandy, I. Sahidin, N.S. Ab Ghani, N.M. Noor, and S.N. Baharum. Plants, 2022. 12(1): p. 59-75. PMID[36616187]. PMCID[PMC9823858].
[PubMed]. HIV_02_2023.

2. New Schiff Base Copper(II) and Nickel(II) Complexes for Biomedical Applications with Reference to SARS-CoV-2 and HIV Virus. Aprajita and M. Choudhary. Indian Journal of Chemistry, 2022. 61(12): p. 1241-1256. ISI[000903819500001].
[WOS]. HIV_02_2023.

3. Identification of "Dual-site"-binding Diarylpyrimidines Targeting Both NNIBP and the NNRTI Adjacent Site of the HIV-1 Reverse Transcriptase. Feng, D., X. Zuo, F. Zhao, H. Lin, J. Dai, Y. Sun, E. Clercq, C. Pannecouque, D. Kang, X. Liu, and P. Zhan. European Journal of Medicinal Chemistry, 2023. 247: 115045. PMID[36577216].
[PubMed]. HIV_02_2023.

4. Potent Long-acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold. Gillis, E.P., K. Parcella, M. Bowsher, J.H. Cook, C. Iwuagwu, B.N. Naidu, M. Patel, K. Peese, H. Huang, L. Valera, C. Wang, K. Kieltyka, D.D. Parker, J. Simmermacher, E. Arnoult, R.T. Nolte, L. Wang, J.A. Bender, D.B. Frennesson, M. Saulnier, A.X. Wang, N.A. Meanwell, M. Belema, U. Hanumegowda, S. Jenkins, M. Krystal, J.F. Kadow, M. Cockett, and R. Fridell. Journal of Medicinal Chemistry, 2023. 66(3): p. 1941-1954. PMID[36719971].
[PubMed]. HIV_02_2023.

5. Inhibition of HIV-1 Protease by a Boronic acid with High Oxidative Stability. Graham, B.J., I.W. Windsor, and R.T. Raines. ACS Medicinal Chemistry Letters, 2023. 14(2): p. 171-175. PMID[36793428]. PMCID[PMC9923841].
[PubMed]. HIV_02_2023.

6. In Vitro anti-HIV-1 Activity of Chitosan Oligomers N-conjugated with Asparagine and Glutamine. Karadeniz, F. BioTech, 2023. 12(1): 18. PMID[36810445]. PMCID[PMC9944945].
[PubMed]. HIV_02_2023.

7. Low-molecular-weight anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins. Kobayakawa, T., M. Yokoyama, K. Tsuji, M. Fujino, M. Kurakami, T. Onishi, S. Boku, T. Ishii, Y. Miura, K. Shinohara, Y. Kishihara, N. Ohashi, O. Kotani, T. Murakami, H. Sato, and H. Tamamura. RSC Advances, 2023. 13(3): p. 2156-2167. PMID[36712613]. PMCID[PMC9834766].
[PubMed]. HIV_02_2023.

8. A Practical Approach to Bicyclic Carbamoyl pyridones with Application to the Synthesis of HIV-1 Integrase Strand Transfer Inhibitors. Mahajan, P.S., S.J. Smith, S.H. Hughes, X. Zhao, and T.R. Burke, Jr. Molecules, 2023. 28(3): p. 1428-1442. PMID[36771093]. PMCID[PMC9919513].
[PubMed]. HIV_02_2023.

9. A Camptothetin Analog, Topotecan, Promotes HIV Latency via Interference with HIV Transcription and RNA Splicing. Mukim, A., D.M. Smith, S. Deshmukh, A.A. Qazi, and N. Beliakova-Bethell. Journal of Virology, 2023. 97(2): e0163022. PMID[36719238]. PMCID[PMC9973035].
[PubMed]. HIV_02_2023.

10. Design and Synthesis of Novel HIV-1 NNRTIs with Bicyclic Cores and with Improved Physicochemical Properties. Prener, L., O. Baszczyňski, M.M. Kaiser, M. Dračínský, G. Stepan, Y.J. Lee, B. Brumshtein, H. Yu, P. Jansa, E.B. Lansdon, and Z. Janeba. Journal of Medicinal Chemistry, 2023. 66(3): p. 1761-1777. PMID[36652602].
[PubMed]. HIV_02_2023.

11. From Design to Biological Mechanism Evaluation of Phenylalanine-bearing HIV-1 Capsid Inhibitors Targeting a Vital Assembly Interface. Xu, S.J., L. Sun, W.A. Zalloum, X.J. Zhang, T.G. Huang, D. Ding, Y.C. Tao, F.B. Zhao, S.H. Gao, D.W. Kang, E. De Clercq, C. Pannecouque, A. Dick, S. Cocklin, X.Y. Liu, and P. Zhan. Chinese Chemical Letters, 2023. 34(3): p. 107611-107616. ISI[000922114100001].
[WOS]. HIV_02_2023.

Patent Citations

This month, no relevant HIV patents were identified.